BCM
IRMD icon

Bridgeway Capital Management’s iRadimed IRMD Stock Holding History

Bridgeway Capital Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-14,400
Closed -$433K – 1414
2022
Q3 		$433K Hold
14,400
– – 0.01% 925
2022
Q2 		$489K Sell
14,400
-3,996
-22% -$143K 0.01% 881
2022
Q1 		$825K Buy
18,396
+3,996
+28% +$185K 0.02% 822
2021
Q4 		$665K Hold
14,400
– – 0.01% 906
2021
Q3 		$484K Sell
14,400
-4,500
-24% -$153K 0.01% 1043
2021
Q2 		$556K Hold
18,900
– – 0.01% 1038
2021
Q1 		$487K Buy
+18,900
New +$452K 0.01% 1090

Other funds holding IRMD

NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMC
RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return
BCM
Bares Capital Management Austin, Texas $1.08B AUM 38.13% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bridgeway Capital Management's IRMD Position: Q4 2022 in Review

Bridgeway Capital Management sold out of iRadimed (IRMD) in Q4 2022, closing a stake of 14,400 shares — an estimated $433K sold.

Bridgeway Capital Management first reported a position in IRMD in Q1 2021 and held it in 7 quarters. The position peaked at $825K in Q1 2022. 79 funds tracked by Wall St. Rank hold IRMD as of Q4 2022.

  • Bridgeway Capital Management reported no remaining iRadimed position as of Q4 2022 after selling out during the quarter.
  • Bridgeway Capital Management sold 14,400 iRadimed shares in Q4 2022, an estimated $433K.
  • Bridgeway Capital Management first reported a position in iRadimed in Q1 2021 and held it in 7 quarters.
  • Bridgeway Capital Management's iRadimed position peaked at $825K in Q1 2022.
  • 79 funds tracked by Wall St. Rank held iRadimed as of Q4 2022.

Based on Bridgeway Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.